Phase 3 Clinical Trial of AF-0901 - Open-label study in patients aged 15 years old or more with convulsive status epilepticus -
Latest Information Update: 16 Mar 2022
At a glance
- Drugs Midazolam (Primary)
- Indications Seizures
- Focus Registrational; Therapeutic Use
- Sponsors Alfresa Pharma Corporation
- 22 Dec 2021 New trial record